Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus plantarum H6 is a specific strain of the species Lactiplantibacillus plantarum, a Gram-positive lactic acid bacterium widely recognized for its probiotic properties. While detailed clinical data on the unique characteristics of the H6 strain are limited in public sources, L. plantarum strains in general are known to modulate gut microbiota, enhance intestinal barrier function, and exert anti-inflammatory and antioxidant effects. These mechanisms contribute to potential benefits in metabolic health (such as improving obesity, diabetes, non-alcoholic fatty liver disease), cardiovascular health (including cholesterol reduction), and immune modulation. The mechanism of action involves competitive exclusion of pathogens, production of beneficial metabolites like short-chain fatty acids (SCFAs), regulation of cytokine production, enhancement of antioxidant enzyme activity, and modulation of bile acid metabolism[3][5][6]. L. plantarum strains are commonly used as probiotics in dietary supplements and functional foods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactobacillus plantarum H6.